KYTX Competitors & Alternatives
Compare Kyverna Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
KYTX
Main Stock$7.26
Tradestie Score
41
Market Cap
$258.18M
Analyst Upside
+318.7%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$8.21
|
$468.01M | - | 47 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$14.07
|
$463.20M | - | 65 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.70
|
$457.09M | - | 40 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.53
|
$454.29M | - | 42 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$12.51
|
$448.32M | - | 41 | Compare |
|
AUTL
Autolus Therapeutics plc American Depositary Share
|
$1.88
|
$444.46M | - | 42 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$9.18
|
$422.50M | - | 53 | Compare |
More KYTX Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry